Contributors

Paul Greengard of Rockefeller University shared the 2000 Nobel Prize in Medicine or Physiology for his work on signal transduction in the brain. He and Per Svenningsson, of the Rockefeller and the Karolinska Institute in Stockholm, write on page 40 about the discovery of DARPP-32 and its subsequent characterization as a master regulator in the brain, integrating signals involved in drugs of abuse as well as schizophrenia and depression. "One of the major challenges was to prove


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Paul Greengard of Rockefeller University shared the 2000 Nobel Prize in Medicine or Physiology for his work on signal transduction in the brain. He and Per Svenningsson, of the Rockefeller and the Karolinska Institute in Stockholm, write on page 40 about the discovery of DARPP-32 and its subsequent characterization as a master regulator in the brain, integrating signals involved in drugs of abuse as well as schizophrenia and depression. "One of the major challenges was to prove that these pathways were physiologically relevant," Greengard says. "We know much more now that I would have guessed possible 25 years ago."

In 2000, Gene Logic CEO Mark Gessler realized his company was sitting on a potential treasure drove of data from tissue from surgery patients on some form of medication: the data could conceivably be used to identify new uses for marketed drugs. The only problem was that the company lacked the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo